Ocular Science®: Company Market Research Report

Company Overview

• Name: Ocular Science®

• Mission: To provide innovative and affordable eye care products that are easy to use, cost-effective, and promote patient compliance. Ocular Science® focuses on paradigm-shifting therapeutic solutions in corrective eye care.

• Founded: 2015

• Founders: Anthony Sampietro (CEO), Damien Goldberg, MD (Chief Medical Officer), and Francis Mah, MD

• Key People:

• Anthony Sampietro: President & Chief Executive Officer

• Damien Goldberg, MD: Co-Founder & Chief Medical Officer

• Francis Mah, MD: Co-Founder & Chief Medical Advisory Board Member

• Eric Garner: Chief Commercial Officer

• Traci Inman: Vice President of Sales

• Vanessa Assam-Gorski: Marketing Manager

• Amy Castillo: Office & Events Manager

• Headquarters: 118 Center Street, El Segundo, California, 90245

• Number of Employees: No information is available

• Revenue: No information is available

• Known For: Ocular Science® is known for developing innovative biotech solutions in ophthalmology, particularly their compounded ophthalmic products that simplify treatment regimens for patients and physicians.

Products

• Product Name: Compounded Ophthalmic Products

• High-Level Description: Ocular Science® provides compounded pharmaceutical solutions that combine multiple medications into a single dose, aimed at improving patient compliance and affordability.

• Key Features:

• Simplification of treatment plans for better compliance.

• Cost-effective pharmaceutical solutions.

• Adaptable to both physicians' and patients' needs.

• Additional Products: No information is available

Recent Developments

• Recent Developments: Ocular Science® announced the appointment of three distinguished ophthalmologists to its Medical Advisory Board: Dr. Daniel Pluznik, Dr. Navin Tekwani, and Dr. Alexander de Castro-Abeger.

• New Products: No information is available

• New Features Added to Existing Products: No information is available

• Partnerships: The medical advisory board’s expansion with renowned ophthalmologists indicates an increasing collaboration with leading professionals in the field to enhance the company's clinical solutions and patient outcomes.

This report aims to provide a comprehensive overview of Ocular Science® based on available data, highlighting its mission-driven approach and key capabilities in the corrective eye care industry. However, data limitations exist in areas such as detailed product descriptions and financial performance.